Back to
Tudor Investment Corp.
IOVA
Showing 8 of 24 quarters
Position history for
Tudor Investment Corp.'s holdings in Iovance Biotherapeutics, Inc.
Yes. Tudor Investment holds 293,989 shares of IOVA (Iovance Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 77,985 shares (+36.1%) from Q1 2026. Tudor Investment has held IOVA since Q3 2025, across 4 quarterly 13F filings.
Current Value
$1.2M
Current Shares
293,989
Total Value Change
-$832,731
Total Shares Change
+75,062
Quarter-by-Quarter History